We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UUUU.WS
10601
DELISTED
Energy Fuels Inc.
UUUU.WS
$27K ﹤0.01%
13,148
-2,816
-18% -$2.34K
SPRT
10602
DELISTED
support.com, Inc.
SPRT
$27K ﹤0.01%
+12,217
New +$24.9K
YDKG
10603
Yueda Digital Holding
YDKG
$5.81M
$26K ﹤0.01%
+30
New +$14K
CYTO
10604
DELISTED
Altamira Therapeutics Ltd
CYTO
$26K ﹤0.01%
+25
New +$16.1K
INFI
10605
PUT
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$26K ﹤0.01%
+12,200
New +$20.1K
TYME
10606
CALL
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$26K ﹤0.01%
+21,300
New +$21.8K
RRD
10607
PUT
DELISTED
RR Donnelley & Sons Co.
RRD
$26K ﹤0.01%
+11,500
New +$17.3K
KOR
10608
DELISTED
Corvus Gold Inc. Common Shares
KOR
$26K ﹤0.01%
11,079
-31,521
-74% -$78.5K
LCTX icon
10609
Lineage Cell Therapeutics
LCTX
$268M
$25K ﹤0.01%
+13,896
New +$19.4K
OCGN icon
10610
Ocugen
OCGN
$451M
$25K ﹤0.01%
+13,884
New +$6.69K
CNSY
10611
Cerenome, Inc. Common Stock
CNSY
$24.5M
$25K ﹤0.01%
33
-27
-45% -$23.1K
CCLP
10612
CALL
DELISTED
CSI Compressco LP
CCLP
$25K ﹤0.01%
+23,200
New +$21.9K
NM
10613
PUT
DELISTED
Navios Maritime Holdings Inc.
NM
$25K ﹤0.01%
+11,200
New +$22.7K
RIBT
10614
DELISTED
RiceBran Technologies
RIBT
$25K ﹤0.01%
4,084
+1,024
+33% +$5.57K
DNN icon
10615
PUT
Denison Mines
DNN
$3.01B
$24K ﹤0.01%
+37,600
New +$16.1K
HEPA
10616
DELISTED
Hepion Pharmaceuticals
HEPA
$24K ﹤0.01%
11
-9
-45% -$23.3K
HSDT icon
10617
Solana Company
HSDT
$103M
0
MATH icon
10618
Metalpha Technology Holding
MATH
$42.3M
$24K ﹤0.01%
+10,494
New +$29K
YHGJ icon
10619
Yunhong Green CTI Ltd
YHGJ
$8.87M
$24K ﹤0.01%
+1,397
New +$26.3K
CTHR
10620
DELISTED
Charles & Colvard Ltd
CTHR
$24K ﹤0.01%
+1,935
New +$20.7K
QTT
10621
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$24K ﹤0.01%
1,521
-10,135
-87% -$238K
MTL
10622
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$24K ﹤0.01%
11,792
-5,781
-33% -$9.13K
PME
10623
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$24K ﹤0.01%
+13,139
New +$27K
AMS icon
10624
American Shared Hospital Services
AMS
$10.6M
$23K ﹤0.01%
10,298
-5,607
-35% -$10.9K
GGE
10625
DELISTED
Green Giant Inc. Common Stock
GGE
$23K ﹤0.01%
+13,133
New +$20.5K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.